Ticker Details
Lexicon Pharmaceuticals, Inc. Lexicon Pharmaceuticals Inc operates as a biopharmaceutical company engaged in discovery and development of breakthrough treatments for human disease. The company mainly designs and develops drugs for therapeutic areas.
IPO Date:	June 23, 2000
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$614.26M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.13 | 3.55%
Avg Daily Range (30 D):	$0.07 | 4.76%
Avg Daily Range (90 D):	$0.05 | 3.61%

Institutional Daily Volume
Avg Daily Volume:	1.15M
Avg Daily Volume (30 D):	3.21M
Avg Daily Volume (90 D):	2.25M

Trade Size
Avg Trade Size (Sh.):	224
Avg Trade Size (Sh.) (30 D):	351
Avg Trade Size (Sh.) (90 D):	353

Institutional Trades
Total Institutional Trades:	1,003
Avg Institutional Trade:	$1.49M
Avg Institutional Trade (30 D):	$.6M
Avg Institutional Trade (90 D):	$.91M
Avg Institutional Trade Volume:	.2M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.29M
Avg Closing Trade (30 D):	$.6M
Avg Closing Trade (90 D):	$.91M
Avg Closing Volume:	197.83K

News

Feb 6, 2026 @ 10:17 PM Lexicon Announces Closing of Approximately $94.6 M... Source: Na

Feb 6, 2026 @ 10:17 PM Lexicon Announces Closing of Approximately $94.6 M... Source: Globe Newswire

Jan 30, 2026 @ 7:50 AM Lexicon Announces Pricing of Approximately $94.6 M... Source: Na

Nov 8, 2025 @ 7:30 PM Clinical Data Demonstrating Efficacy of Sotagliflo... Source: Lexicon Pharmaceuticals

Sep 22, 2025 @ 8:00 PM Lexicon Pharmaceuticals Announces Update on Submis... Source: Lexicon Pharmaceuticals

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-.19	$-.04	$.01
Diluted EPS	$-.19	$-.04	$.01
Revenue	$70.86M	$14.18M	$28.87M
Gross Profit	$70.44M	$14.17M	$28.83M
Net Income / Loss	$-68.58M	$-12.77M	$3.25M
Operating Income / Loss	$-66.87M	$-12.19M	$3.74M
Cost of Revenue	$.42M	$.01M	$.03M
Net Cash Flow	$44.11M	$28.29M	$-12.52M
PE Ratio

Splits
May 21, 2015	1:7